johnson & johnson - Search News

Johnson & Johnson Q4 Profit Decreases

Johnson & Johnson surpassed earnings expectations with strong sales, but it faces challenges ahead due to patent expirations.

Business Insider · 8h

Johnson & Johnson Q4 Profit Decreases, But Beats Estimates

Johnson & Johnson (JNJ) announced a profit for fourth quarter that decreased from last year but beat the Street estimates. The

AOL · 4h

Johnson & Johnson stock down despite beat on full-year, Q4 2024 earnings

Johnson & Johnson beat on fourth quarter and full-year 2024 results, but its stock traded down on Wednesday morning to about $143 per share. Several negative impacts were highligh

Zacks.com on MSN · 7h

Johnson & Johnson (JNJ) Q4 Earnings and Revenues Top Estimates

Johnson & Johnson (JNJ) came out with quarterly earnings of $2.04 per share, beating the Zacks Consensus Estimate of $2 per share. This compares to earnings of $2.29 per share a year ago. These figures are adjusted for non-recurring items.

Bears Hire Ben Johnson

USA Today · 1d

Detroit Lions fans crush Ben Johnson for leaving to Chicago Bears: 'Benedict Johnson'

Some Detroit Lions fans are beside themselves that Ben Johnson is staying in the NFC North with the Chicago Bears: 'Benedict Johnson'

The Washington Post · 1d

Ben Johnson agrees to become Bears head coach

Detroit Lions offensive coordinator Ben Johnson has agreed to become the Chicago Bears head coach, a person familiar with the situation told The Associated Press Ben Johnson helped Jared Goff establish himself as one of the NFL’s top quarterbacks.

Fox Sports · 52m

Tom Brady on the Bears hiring Ben Johnson | The Herd

The Chicago Bears have hired Ben Johnson as their next head coach. Colin Cowherd and Tom Brady discuss the move and what it means for the Bears and Caleb Williams.

Bronstein, Gewirtz & Grossman, LLC Encourages Johnson & Johnson (JNJ) Shareholders to Inquire about Securities Investigation

NEW YORK, NY / ACCESS Newswire / January 22, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on ...

1don MSN

FDA approves Johnson & Johnson’s nasal spray for depression as stand-alone treatment

Spravato is now the first-ever stand-alone therapy for treatment-resistant depression, and is on its way to becoming a ...

3hon MSN

Johnson & Johnson clears a few hurdles, but Wall Street focuses on weak guidance

Johnson & Johnson’s stock dropped more than 3% Wednesday after the medical-technology and drug company beat estimates for the fourth quarter but as lower sales guidance for the year stoked fears of ...

Johnson & Johnson says positioned for 5%-7% growth through 2030 and beyond

Says starting 2025 from a position of strength. Says invested ~$50B in R&D and M&A in 2024. Says continues to invest in R&D at ...

MassDevice7h

Johnson & Johnson MedTech sales grow 6.2% in 2025, driven by EP, Abiomed

Johnson & Johnson (NYSE: JNJ) shares dipped slightly before hours today on fourth-quarter results that topped the consensus ...

14h

Johnson & Johnson Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

Johnson & Johnson has secured FDA approval for expanded use of its Spravato nasal spray, now cleared as a standalone ...

TipRanks on MSN3d

Johnson & Johnson’s New Acquisition Could Result in Tremendous Rewards

Staying ahead of the competition is critical in every sector, particularly in the dynamic healthcare space, where a single ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results

Johnson & Johnson Q4 Profit Decreases

Bears Hire Ben Johnson

Related topics